Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Merck KGaA Looks to Sell Consumer Health Biz | Contract Pharma
Breaking News

Merck KGaA Looks to Sell Consumer Health Biz

Shifts strategic focus on science and technology

Merck KGaA of Darmstadt, Germany, is looking at strategic options for the potential sale of its Consumer Health business.

“We have continued to transform Merck KGaA, Darmstadt, Germany, over the last years into a leading science and technology company. Thereby we regularly review our portfolio in the context of our innovation driven strategy. Healthcare largely focuses on its Biopharma pipeline,” said Stefan Oschmann, chairman of the executive board and chief executive officer of Merck KGaA, Darmstadt, Germany.

The Consumer Health business includes several leading OTC products and achieved sales of €860 million in 2016. Brands and products include Bion, Femibion, Nasivin, Neurobion, and Seven Seas.

Merck KGaA has been shifting its focus to become a science and technology company with acquisitions of Sigma-Aldrich, AZ Electronic Materials and Millipore, as well as the divestment of its Biosimilars business.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters